Reference
Retel VP, et al. Prospective cost-effectiveness analysis of genomic profiling in breast cancer. European Journal of Cancer : 27 Aug 2013. Available from: URL: http://dx.doi.org/10.1016/j.ejca.2013.08.001
Rights and permissions
About this article
Cite this article
70-gene signature profiling dominates in breast cancer. PharmacoEcon Outcomes News 687, 5 (2013). https://doi.org/10.1007/s40274-013-0714-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0714-x